September 20 - 23, 2014
Sheraton Philadelphia Downtown
Philadelphia, Pennsylvania, USA
Abstract submission deadline: Friday, August 8
Advance registration deadline: Monday, August 4
Educational Session: Molecular Pathology and Classification of Hematological MalignanciesSession Chairperson: Clara D. Bloomfield, The Ohio State University, Columbus, Ohio4:00 p.m.-5:30 p.m.
Clinical significance of molecular findings in acute myeloid leukemiaClara D. Bloomfield
Principles of lymphoma classificationLaurence DeLeval, University Hospital of Lausanne, Lausanne, Switzerland
Genetic landscape of myeloma and its clinical significance Faith Davies, Institute of Cancer Research and Royal Marsden Hospital, London, U.K.
Free Time / Dinner on Own5:30 p.m.-6:30 p.m.
Welcome and Opening Keynote SessionSession Chairperson: Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston, Mass.6:30 p.m.-9:00 p.m.
Welcome Remarks Margaret Foti, CEO, American Association for Cancer ResearchKenneth C. Anderson, Conference Chairperson
The future of epigenetics: Cancer therapy through cellular rehabilitation rather than executionCraig B. Thompson, Memorial Sloan Kettering Cancer Center, New York, N.Y.
The accomplishments and impact of Janet D. RowleyMichelle M. Le Beau, University of Chicago Comprehensive Cancer Center, Chicago, Ill.
Keynote Memorial Lecture, dedicated to Janet D. RowleyNovel function of microRNAsCarlo M. Croce, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Opening Reception9:00 p.m.-10:30 p.m.